Fiellin DA - Search Results

1

Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans.

Kraemer KL, McGinnis KA, Fiellin DA, Skanderson M, Gordon AJ, Robbins J, Zickmund S, Bryant K, Korthuis PT. Kraemer KL, et al. Among authors: fiellin da. J Subst Abuse Treat. 2019 Aug;103:23-32. doi: 10.1016/j.jsat.2019.05.007. Epub 2019 May 7. J Subst Abuse Treat. 2019. PMID: 31229189 Free PMC article.

2

Coordination of medical care and opioid dependence treatment in primary care: a case report.

Fiellin DA, Rosenheck RA, Kosten TR. Fiellin DA, et al. Subst Abus. 2003 Mar;24(1):43-6. doi: 10.1080/08897070309511532. Subst Abus. 2003. PMID: 12652094 No abstract available.

3

Substance use of disorders in HIV-infected patients: impact and new treatment strategies.

Fiellin DA. Fiellin DA. Top HIV Med. 2004 Jul-Aug;12(3):77-82. Top HIV Med. 2004. PMID: 15310938 Free article. Review.

4

Consensus statement on office-based treatment of opioid dependence using buprenorphine.

Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR. Fiellin DA, et al. J Subst Abuse Treat. 2004 Sep;27(2):153-9. doi: 10.1016/j.jsat.2004.06.005. J Subst Abuse Treat. 2004. PMID: 15450648 Review.

5

Provider satisfaction with office-based treatment of opioid dependence: a systematic review.

Becker WC, Fiellin DA. Becker WC, et al. Among authors: fiellin da. Subst Abus. 2005 Mar;26(1):15-22. doi: 10.1300/j465v26n01_02. Subst Abus. 2005. PMID: 16492659 Review.

6

Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans.

Kraemer KL, McGinnis KA, Skanderson M, Cook R, Gordon A, Conigliaro J, Shen Y, Fiellin DA, Justice AC. Kraemer KL, et al. Among authors: fiellin da. Med Care. 2006 Aug;44(8 Suppl 2):S44-51. doi: 10.1097/01.mlr.0000223703.91275.78. Med Care. 2006. PMID: 16849968

7

Training HIV physicians to prescribe buprenorphine for opioid dependence.

Sullivan LE, Tetrault J, Bangalore D, Fiellin DA. Sullivan LE, et al. Among authors: fiellin da. Subst Abus. 2006 Sep;27(3):13-8. doi: 10.1300/J465v27n03_03. Subst Abus. 2006. PMID: 17135176

8

Update in addiction medicine for the generalist.

Gordon AJ, Sullivan LE, Alford DP, Arnsten JH, Gourevitch MN, Kertesz SG, Kunins HV, Merrill JO, Samet JH, Fiellin DA. Gordon AJ, et al. Among authors: fiellin da. J Gen Intern Med. 2007 Aug;22(8):1190-4. doi: 10.1007/s11606-007-0133-4. Epub 2007 May 10. J Gen Intern Med. 2007. PMID: 17492327 Free PMC article. Review. No abstract available.

9

Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence.

Chawarski MC, Fiellin DA, O'Connor PG, Bernard M, Schottenfeld RS. Chawarski MC, et al. Among authors: fiellin da. J Subst Abuse Treat. 2007 Dec;33(4):411-5. doi: 10.1016/j.jsat.2007.03.004. Epub 2007 May 23. J Subst Abuse Treat. 2007. PMID: 17512157 Free PMC article. Clinical Trial.

10

Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.

Sullivan LE, Moore BA, Chawarski MC, Pantalon MV, Barry D, O'Connor PG, Schottenfeld RS, Fiellin DA. Sullivan LE, et al. Among authors: fiellin da. J Subst Abuse Treat. 2008 Jul;35(1):87-92. doi: 10.1016/j.jsat.2007.08.004. Epub 2007 Oct 15. J Subst Abuse Treat. 2008. PMID: 17933486 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

392 results

Search Page